Diamedica Therapeutics(DMAC)
$8.79-0.54 (-5.79%)
DMAC
Diamedica Therapeutics ownership
$8.79
At close:-0.54 (-5.79%)
Want to see DMAC full AI Analyst Report?
Diamedica Therapeutics (DMAC) Ownership - Who Owns Diamedica Therapeutics?
573 Followers
Diamedica Therapeutics (DMAC) Ownership Overview
- 17.80% Insiders
- 3.18% Mutual Funds
- 3.98% ETFs
- 75.04% Public Companies and Individual Investors
The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. Approximately 7.16% of the company’s stock is owned by Institutional Investors, 17.80% is owned by Insiders, and 75.04% is owned by Public Companies and Individual Investors.
The ownership structure of Diamedica Therapeutics (DMAC) stock is a mix of institutional, retail, and individual investors. Approximately 7.16% of the company’s stock is owned by Institutional Investors, 17.80% is owned by Insiders, and 75.04% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 07, 2025 | Jan Stahlberg | $7,624,976 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Jan Stahlberg | 8,825,742 | Insider | 16.36% | 77,578,272 |
| Ishares | 1,394,853 | Institution | 2.59% | 12,260,758 |
| Vanguard | 617,239 | Institution | 1.14% | 5,425,531 |
| Randall Michael Giuffre | 445,230 | Insider | 0.83% | 3,913,572 |
| Fidelity Salem Street Trust | 438,618 | Institution | 0.81% | 3,855,452 |
| Vanguard Index Funds | 355,523 | Institution | 0.66% | 3,125,047 |
| Fidelity Concord Street Trust | 325,496 | Institution | 0.60% | 2,861,110 |
| Vanguard Scottsdale Funds | 252,270 | Institution | 0.47% | 2,217,453 |
| Dietrich John Pauls | 128,791 | Insider | 0.24% | 1,132,073 |
| Schwab Capital Trust | 101,638 | Institution | 0.19% | 893,398 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Salem Street Trust | 438,618 | Institution | 0.81% | 3,855,452 |
| Vanguard Index Funds | 355,523 | Institution | 0.66% | 3,125,047 |
| Fidelity Concord Street Trust | 325,496 | Institution | 0.60% | 2,861,110 |
| Vanguard Scottsdale Funds | 252,270 | Institution | 0.47% | 2,217,453 |
| Schwab Capital Trust | 101,638 | Institution | 0.19% | 893,398 |
| Jacob Funds Inc. | 87,730 | Institution | 0.16% | 771,147 |
| Tiaa-cref Funds | 48,349 | Institution | 0.09% | 424,988 |
| Goldman Sachs Trust | 32,817 | Institution | 0.06% | 288,461 |
| Valic Co I | 14,282 | Institution | 0.03% | 125,539 |
| State Street Institutional Investment Trust | 11,200 | Institution | 0.02% | 98,448 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| iShares Russell 2000 ETF, IWM ETF | 935,347 | Institution | 1.73% | 8,221,700 |
| Vanguard Extended Market ETF, VXF ETF | 360,556 | Institution | 0.67% | 2,981,798 |
| iShares Russell 2000 Growth ETF, IWO ETF | 348,101 | Institution | 0.65% | 3,059,808 |
| Vanguard Russell 2000 ETF, VTWO ETF | 213,590 | Institution | 0.40% | 1,766,389 |
| iShares Micro-Cap ETF, IWC ETF | 111,405 | Institution | 0.21% | 979,250 |
| Vanguard Russell 2000 Growth ETF, VTWG ETF | 40,513 | Institution | 0.08% | 335,043 |
| State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR, FR:R2EH ETF | 40,434 | Institution | 0.07% | 377,249 |
| Global X Russell 2000 ETF, RSSL ETF | 17,416 | Institution | 0.03% | 162,491 |
| Invesco Russell 2000 UCITS ETF, GB:RTYS ETF | 3,976 | Institution | <0.01% | 37,100 |
| Vanguard Russell 3000 ETF, VTHR ETF | 2,407 | Institution | <0.01% | 19,906 |
FAQ
Who Owns Diamedica Therapeutics (DMAC)?
According to the latest TipRanks data, approximately 7.16% of the company's stock is held by institutional investors, 17.80% is held by insiders, and 75.04% is held by public companies and individual investors.
What percentage of Diamedica Therapeutics (DMAC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.16% of Diamedica Therapeutics (DMAC) stock is held by institutional investors: 3.18% by mutual funds and 3.98% by ETFs.
What percentage of Diamedica Therapeutics (DMAC) stock is held by retail investors?
According to the latest TipRanks data, approximately 75.04% of Diamedica Therapeutics (DMAC) stock is held by public companies and individual investors.
Who owns the most shares of Diamedica Therapeutics (DMAC)?
JAN STAHLBERG owns the most shares of Diamedica Therapeutics (DMAC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

